Lena Ohannesian, Ph.D. is a esults-driven, and analytical leader with a unique combination of cross-functional development experience and life-cycle management in various therapeutic areas ( Neuroscience ( MS, Pain and Headache), Oncology and IM). Established record in end-to-end R&D strategy setting and managing complex projects through clinical development phases and launch. Proven success in building and managing global high-performance cross-functional teams, managing global alliance programs and partnerships. Strong background in process improvements and compliance. Experience in global product registration and successful interactions with global regulatory agencies. Strong interpersonal and communication skills for bridging between scientific and business partners. Excellent people development and leadership skills. Lena’s key capabilities include Global Program and portfolio Leadership in Neuroscience (e.g. Pain, Migraine, MS) , Oncology and IM for small and large molecules, Late, clinical stage Program Management (phase II, phase III through registration and launch), Management of Life Cycle opportunities, Scientific search and evaluation, Global Alliance Management, Clinical Project managementt, Preclinical stage Project Management., New pharmaceutical dosage development, formulation, analytical development and stability evaluation.